SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-000274
Filing Date
2024-04-01
Accepted
2024-04-01 16:17:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2919
  Complete submission text file 0001968582-24-000274.txt   4394
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38944 | Film No.: 24809526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FL SOUTH SAN FRANCISCO CA 94080
Business Address
Young Jonathan (Reporting) CIK: 0001779805 (see all company filings)

Type: 144